4SC Gives Update on the Clinical Development of its Lead Cancer Compound Resminostat
Thursday, May 30, 2013
Data from completed Phase I part of SHORE study confirms the safety of the resminostat FOLFIRI combination and showing encouraging signs of clinical benefit

LifeScience Alley Announces New Appointments
Thursday, May 30, 2013
Board of directors elects new officers.

MRC and Wellcome Trust Invest £24m in Cambridge Obesity Institute
Thursday, May 30, 2013
The joint venture provides a unique environment linking basic and applied science in metabolic diseases.

Enzyme-Activating Antibodies Revealed As Marker for Severe Rheumatoid Arthritis
Thursday, May 30, 2013
Finding could lead to earlier diagnosis and new, more aggressive treatment for worst cases.

Valeant Pharmaceuticals to Acquire Bausch + Lomb For $8.7 Billion
Wednesday, May 29, 2013
Valeant will finance the transaction with debt and approximately $1.5 - $2.0 billion of new equity.

Researchers Identify Novel Class of Drugs for Prostate Cancers
Wednesday, May 29, 2013
A new study on prostate cancer describes a novel class of drugs that interrupts critical signaling needed for prostate cancer cells to grow.

Greenphire's John Samar Named CFO of the Year Finalist
Wednesday, May 29, 2013
The Philadelphia Business Journal awards honour professionals who have displayed outstanding performance in their roles as corporate financial leaders.

Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Collaborate
Wednesday, May 29, 2013
Partnership will accelerate the pace of discovery and innovation in Biomedical Sciences.

<<	2 3 4 5 6 7 8	>>
Showing Results 41 - 50 of 2319